Clinical Trials Currently Recruiting
See below for further details, or contact us at email@example.com
Revumenib Clinical Trials
A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101).
A Study of SNDX-5613 in Combination With Chemotherapy in Participants With Leukemia (AUGMENT-102).
Axatilimab Clinical Trials
To learn more about our clinical trials, please contact us at firstname.lastname@example.org.
Syndax is very interested in pursuing innovative explorations in science. If you are interested in collaborating with us, please contact us through email@example.com.